Sabra Health Care REIT, Inc.

As of June 30, 2026, Sabra Health Care REIT, Inc. carries a market capitalization of 4.36B, placing it among publicly traded companies globally. Its enterprise value stands at 6.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sabra Health Care REIT, Inc.'s next confirmed earnings release is scheduled for November 2, 2026.

As of June 30, 2026, Sabra Health Care REIT, Inc. has 255.46M shares outstanding.

As of June 30, 2026, Sabra Health Care REIT, Inc. trades at a trailing price-to-earnings ratio of 74.03. The price-to-sales ratio is 5.64, and the price-to-book ratio stands at 1.81.

As of June 30, 2026, Sabra Health Care REIT, Inc. trades at an EV/EBITDA multiple of 20.27 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 8.61 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 47.54 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Sabra Health Care REIT, Inc. trades at an EV/FCF ratio of 15.29, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 6.47B versus a market cap of 4.36B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Sabra Health Care REIT, Inc. maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 96.10, indicating elevated leverage, while an interest coverage ratio of 3.15 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Sabra Health Care REIT, Inc. posted a return on equity (ROE) of 2.40, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 2.84 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.21, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 3.35, useful for judging operating efficiency across full business cycles. The company generates approximately 13.44M in revenue per employee across its workforce of 56.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Sabra Health Care REIT, Inc. recorded 1.87M in income tax expense. That works out to an effective tax rate of 3.16, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 58.96M, leaving 57.28M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on August 13, 2026, Sabra Health Care REIT, Inc.'s stock has gained approximately 10.36% over the past 52 weeks. The 50-day moving average sits at 17.42, while the 200-day moving average is 16.93.

Over the twelve months ended June 30, 2026, Sabra Health Care REIT, Inc. generated 752.37M in revenue and converted that into 57.28M in net income, yielding earnings per share of 0.23. EBITDA reached 319.51M, while operating income came in at 140.41M.

As of June 30, 2026, Sabra Health Care REIT, Inc. holds 202.71M in cash and equivalents against 2.32B in total debt, resulting in a net debt position of 2.10B. Total book value stands at 2.41B, with working capital of -56.01M providing operational flexibility.

Sabra Health Care REIT, Inc. produced 325.24M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Sabra Health Care REIT, Inc. posted a gross margin of 61.84, reflecting its pricing power and cost economics. The operating margin of 18.66 and net profit margin of 7.61 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Sabra Health Care REIT, Inc. paid dividends of 1.05 per share. The dividend payout ratio of 458.43 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 7.59, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -2.01, meaning Sabra Health Care REIT, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Sabra Health Care REIT, Inc. has an Altman Z-Score of 0.77, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.